EARLY AND LATE COMPLICATIONS OF THE NEW CORONAVIRUS INFECTION COVID-19 (LITERATURE REVIEW)
Keywords:
: dorsopathy, neurovascularization, chronic pain, Doppler ultrasound, diabetes mellitus.Abstract
A review of the literature data shows that the main complication in patients with COVID-19, which determines the severity of the disease and fatal outcomes, remains pneumonia in all countries of the world, the etiology of which is considered as a viral-bacterial associated infection, in which there is a high probability of developing diffuse alveolar lesion, manifested clinically by acute respiratory distress syndrome (ARDS). At the same time, bacterial complications that directly affect the patient's health along with the coronavirus exacerbate the severity of the underlying disease. The body's immune response to the virus differs from the reaction it shows to the bacteria present, which increases the severity of COVID-19. Studies have shown that COVID-19 in its most severe manifestations causes the development of interstitial pneumonia, acute respiratory distress syndrome (ARDS), and multiple organ failure.
References
Garg, S. (2020). Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019—COVID-NET, 14 States, March 1–30, 2020. MMWR. Morbidity and mortality weekly report, 69..(in Russ).
Yupatov, E. Yu., Kurmanbaev, T. E., & Timoshkova, Yu. L. (2022). Current understanding of vascular endothelial function and dysfunction. Literature review. RMJ, 30(3), 20-23.
Ackermann, M., Verleden, S. E., Kuehnel, M., Haverich, A., Welte, T., Laenger, F., ... & Jonigk, D. (2020). Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. New England Journal of Medicine, 383(2), 120-128.
Cao, Y. (2021, October). The impact of the hypoxia‐VEGF‐vascular permeability on COVID‐19‐infected patients. In Exploration (Vol. 1, No. 2, p. 20210051).
Glybochko, P. V., Fomin, V. V., Avdeev, S. N., Moiseev, S. V., Yavorovsky, A. G., Brovko, M. Yu., & Yakovleva, A. A. (2020). Clinical characteristics of 1007 patients with severe SARS-CoV-2 pneumonia who required respiratory support. Clinical Pharmacology and Therapeutics, 29(2), 21-29.
Ilchenko L.Yu., Nikitin I.G., Fedorov I.G. (2020). COVID-19 and liver damage. Russian Archive of Internal Medicine, 10 (3), 188-197.
Sabirov, I. S., Murkamilov, I. T., & Fomin, V. V. (2020). Hepatobiliary system and new coronavirus infection (COVID-19). The Scientific Heritage, (49-2), 49-58.
Xiaoqi, W., Xin, B., Xu, Z., Kenli, L. I., Li, F., Zhong, W., ... & Peng, S. (2021). Network representation learning-based drug mechanism discovery and anti-inflammatory response against COVID-19.
Semyonova, S. G. Vascular endothelial growth factor in assessing the severity of COVID-19: materials of the National Congress on Infectious Diseases, Tashkent, March 24-25, 2022 / S. G. Semyonova, V. M. Tsyrkunov, I. A . Kondratovich // Infection, immunity and pharmacology. – 2022. – No. 2 (special issue). – P. 6-12.
Datta, S. D., Talwar, A., & Lee, J. T. (2020). A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: illness beyond acute infection and public health implications. Jama, 324(22), 2251-2252.
El Wahsh, R., Amin, S., & Essa, E. (2011). Diagnostic value of von Willebrand factor (VWF) in patients suffering from respiratory distress.
Escher, R., Breakey, N., & Lämmle, B. (2020). Severe COVID-19 infection associated with endothelial activation. Thrombosis research, 190, 62.
Nekaeva E.S. Clinical significance of hemostasis and endothelial dysfunction in patients who suffered a new coronavirus infection (Covid-19) in the first wave: abstract of the dissertation of a candidate of medical sciences: 3.1.18. Kazan, 2022. - 24 p.
Ackermann, M., Verleden, S. E., Kuehnel, M., Haverich, A., Welte, T., Laenger, F., ... & Jonigk, D. (2020). Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. New England Journal of Medicine, 383(2), 120-128.
Stals, M. A., Grootenboers, M. J., van Guldener, C., Kaptein, F. H., Braken, S. J., Chen, Q., ... & Huisman, M. V. (2021). Risk of thrombotic complications in influenza versus COVID‐19 hospitalized patients. Research and Practice in Thrombosis and Haemostasis, 5(3), 412-420.
Fogarty, H., Townsend, L., Morrin, H., Ahmad, A., Comerford, C., Karampini, E., ... & Fazavana, J. (2021). Persistent endotheliopathy in the pathogenesis of long COVID syndrome. Journal of thrombosis and haemostasis, 19(10), 2546-2553.
Svetozarsky, N. L., Artifeksova, A. A., & Svetozarsky, S. N. (2015). Vascular endothelial growth factor: biological properties and practical significance (literature review). Journal of Siberian Medical Sciences, (5), 24.
Agrawal, H., Das, N., Nathani, S., Saha, S., Saini, S., Kakar, S. S., & Roy, P. (2021). An assessment on impact of COVID-19 infection in a gender specific manner. Stem cell reviews and reports, 17, 94-112.
Talotta, R. (2022). Impaired VEGF-A-mediated neurovascular crosstalk induced by SARS-CoV-2 spike protein: a potential hypothesis explaining long COVID-19 symptoms and COVID-19 vaccine side effects?. Microorganisms, 10(12), 2452.
Hajibeygi , R., Mirghazanfari , S. M., Pahlavani , N., Jalil, A. T., Alshahrani , S. H., Rizaev , J. A., ... & Yekta , N. H. (2022). Effect of a diet based on Iranian traditional medicine on inflammatory markers and clinical outcomes in COVID-19 patients: A double-blind, randomized, controlled trial. European Journal of Integrative Medicine, 102179.
Zeynitdinova , Z. A. , RIZAEV , J. A. , & Oripov , F. WITH . (2022). The degree of cytological damage to the epithelium of the buccal mucosa in COVID-19. JOURNAL OF BIOMEDICINE AND PRACTICE, 7(2).
Umirzakov Zokir , Rizaev Jasur , UMIROV Safar . The phenomenon of the epidemic
covid-19 process and their leading determinants. Journal of Biomedicine and Practice. 2021, vol . 6, issue 6, pp . 286-295
Rizaev , woman A., Kushakov, B. Zh., Rustamova , D. A. (2022). Manifestations of coronavirus infection SARS-COV-2 in the oral cavity. Journal of Biomedicine and Practice, 7(2).
